Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2009

Open Access 01-12-2009 | Case report

Coxiella burnetii as a possible cause of autoimmune liver disease: a case report

Authors: Chloe Kaech, Isabelle Pache, Didier Raoult, Gilbert Greub

Published in: Journal of Medical Case Reports | Issue 1/2009

Login to get access

Abstract

Introduction

Q fever is a zoonotic infection that may cause severe hepatitis. Q-fever hepatitis has not yet been associated with autoimmune hepatitis and/or primary biliary cirrhosis.

Case presentation

We describe a 39-year-old man of Sri Lankan origin with chronic Q-fever hepatitis who developed autoantibodies compatible with autoimmune hepatitis/primary biliary cirrhosis overlap syndrome. Ursodeoxycholic acid in addition to antibiotic therapy markedly improved hepatic enzyme levels suggesting that autoimmunity, potentially triggered by the underlying infection, was involved in the pathogenesis of liver damage.

Conclusion

We suggest that Coxiella burnetii might trigger autoimmune liver disease. Patients with Q-fever hepatitis who respond poorly to antibiotics should be investigated for serological evidence of autoimmune hepatitis, primary biliary cirrhosis or overlap syndrome, as these patients could benefit from adjunctive therapy with ursodeoxycholic acid. Conversely, C. burnetii serology might be necessary in patients with autoimmune liver disease in order to exclude underlying Coxiella infection.
Literature
1.
go back to reference Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R: Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology. 1998, 28: 296-301. 10.1002/hep.510280203.CrossRefPubMed Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R: Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology. 1998, 28: 296-301. 10.1002/hep.510280203.CrossRefPubMed
2.
go back to reference Silveira MG, Talwalkar JA, Angulo P, Lindor KD: Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes. Am J Gastroenterol. 2007, 102: 1244-1250. 10.1111/j.1572-0241.2007.01136.x.CrossRefPubMed Silveira MG, Talwalkar JA, Angulo P, Lindor KD: Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes. Am J Gastroenterol. 2007, 102: 1244-1250. 10.1111/j.1572-0241.2007.01136.x.CrossRefPubMed
3.
go back to reference Chazouilleres O, Wendum D, Serfaty L, Rosmorduc O, Poupon R: Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. J Hepatol. 2006, 44: 400-406. 10.1016/j.jhep.2005.10.017.CrossRefPubMed Chazouilleres O, Wendum D, Serfaty L, Rosmorduc O, Poupon R: Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. J Hepatol. 2006, 44: 400-406. 10.1016/j.jhep.2005.10.017.CrossRefPubMed
5.
go back to reference Sanmarco M, Soler C, Christides C, Raoult D, Weiller PJ, Gerolami V, Bernard D: Prevalence and clinical significance of IgG isotype anti-beta 2-glycoprotein I antibodies in antiphospholipid syndrome: a comparative study with anticardiolipin antibodies. J Lab Clin Med. 1997, 129: 499-506. 10.1016/S0022-2143(97)90004-4.CrossRefPubMed Sanmarco M, Soler C, Christides C, Raoult D, Weiller PJ, Gerolami V, Bernard D: Prevalence and clinical significance of IgG isotype anti-beta 2-glycoprotein I antibodies in antiphospholipid syndrome: a comparative study with anticardiolipin antibodies. J Lab Clin Med. 1997, 129: 499-506. 10.1016/S0022-2143(97)90004-4.CrossRefPubMed
6.
go back to reference Levy P, Raoult D, Razongles JJ: Q-fever and autoimmunity. Eur J Epidemiol. 1989, 5: 447-453. 10.1007/BF00140139.CrossRefPubMed Levy P, Raoult D, Razongles JJ: Q-fever and autoimmunity. Eur J Epidemiol. 1989, 5: 447-453. 10.1007/BF00140139.CrossRefPubMed
7.
go back to reference Lindor K: Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. N Engl J Med. 2007, 357: 1524-1529. 10.1056/NEJMct074694.CrossRefPubMed Lindor K: Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. N Engl J Med. 2007, 357: 1524-1529. 10.1056/NEJMct074694.CrossRefPubMed
8.
go back to reference Albert LJ, Inman RD: Molecular mimicry and autoimmunity. N Engl J Med. 1999, 341: 2068-2074. 10.1056/NEJM199912303412707.CrossRefPubMed Albert LJ, Inman RD: Molecular mimicry and autoimmunity. N Engl J Med. 1999, 341: 2068-2074. 10.1056/NEJM199912303412707.CrossRefPubMed
11.
go back to reference Roesler KW, Schmider W, Kist M, Batsford S, Schiltz E, Oelke M, Tuczek A, Dettenborn T, Behringer D, Kreisel W: Identification of beta-subunit of bacterial RNA-polymerase - a non-species-specific bacterial protein - as target of antibodies in primary biliary cirrhosis. Dig Dis Sci. 2003, 48: 561-569. 10.1023/A:1022501102877.CrossRefPubMed Roesler KW, Schmider W, Kist M, Batsford S, Schiltz E, Oelke M, Tuczek A, Dettenborn T, Behringer D, Kreisel W: Identification of beta-subunit of bacterial RNA-polymerase - a non-species-specific bacterial protein - as target of antibodies in primary biliary cirrhosis. Dig Dis Sci. 2003, 48: 561-569. 10.1023/A:1022501102877.CrossRefPubMed
Metadata
Title
Coxiella burnetii as a possible cause of autoimmune liver disease: a case report
Authors
Chloe Kaech
Isabelle Pache
Didier Raoult
Gilbert Greub
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2009
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.4076/1752-1947-3-8870

Other articles of this Issue 1/2009

Journal of Medical Case Reports 1/2009 Go to the issue